239 related articles for article (PubMed ID: 36999028)
1. Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy.
Ren C; Li Y; Cong Z; Li Z; Xie L; Wu S
Front Immunol; 2023; 14():1129771. PubMed ID: 36999028
[TBL] [Abstract][Full Text] [Related]
2.
Liang R; Li P; Yang N; Xiao X; Gong J; Zhang X; Bai Y; Chen Y; Xie Z; Liao Q
Drug Des Devel Ther; 2024; 18():1833-1853. PubMed ID: 38828018
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages.
Hu R; Lin H; Li J; Zhao Y; Wang M; Sun X; Min Y; Gao Y; Yang M
BMC Microbiol; 2020 Aug; 20(1):268. PubMed ID: 32854612
[TBL] [Abstract][Full Text] [Related]
4. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy.
Li Y; Wu J; Qiu X; Dong S; He J; Liu J; Xu W; Huang S; Hu X; Xiang DX
Bioact Mater; 2023 Feb; 20():548-560. PubMed ID: 35846843
[TBL] [Abstract][Full Text] [Related]
5. Robust Immune Response Induced by
Barbosa MMF; Kanno AI; Barazzone GC; Rodriguez D; Pancakova V; Trentini M; Faquim-Mauro EL; Freitas AP; Khouri MI; Lobo-Silva J; Goncalves VM; Schenkman RPF; Tanizaki MM; Boraschi D; Malley R; Farias LP; Leite LCC
Int J Nanomedicine; 2021; 16():7153-7168. PubMed ID: 34712047
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects, cell selectivity and structure-activity relationship of a novel antimicrobial peptide polybia-MPI.
Wang KR; Zhang BZ; Zhang W; Yan JX; Li J; Wang R
Peptides; 2008 Jun; 29(6):963-8. PubMed ID: 18328599
[TBL] [Abstract][Full Text] [Related]
7. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
[TBL] [Abstract][Full Text] [Related]
8. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses.
Pfalzgraff A; Correa W; Heinbockel L; Schromm AB; Lübow C; Gisch N; Martinez-de-Tejada G; Brandenburg K; Weindl G
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1503-1513. PubMed ID: 31163264
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of Salmonella Typhimurium outer membrane nanovesicles.
Aly RG; El-Enbaawy MI; Abd El-Rahman SS; Ata NS
Exp Cell Res; 2021 Feb; 399(1):112423. PubMed ID: 33338480
[TBL] [Abstract][Full Text] [Related]
11. Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy
Li Y; Zhao R; Cheng K; Zhang K; Wang Y; Zhang Y; Li Y; Liu G; Xu J; Xu J; Anderson GJ; Shi J; Ren L; Zhao X; Nie G
ACS Nano; 2020 Dec; 14(12):16698-16711. PubMed ID: 33232124
[TBL] [Abstract][Full Text] [Related]
12. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC).
Hu R; Li J; Zhao Y; Lin H; Liang L; Wang M; Liu H; Min Y; Gao Y; Yang M
Microb Cell Fact; 2020 Jun; 19(1):119. PubMed ID: 32493405
[TBL] [Abstract][Full Text] [Related]
13. Inflammasome Activation by Bacterial Outer Membrane Vesicles Requires Guanylate Binding Proteins.
Finethy R; Luoma S; Orench-Rivera N; Feeley EM; Haldar AK; Yamamoto M; Kanneganti TD; Kuehn MJ; Coers J
mBio; 2017 Oct; 8(5):. PubMed ID: 28974614
[TBL] [Abstract][Full Text] [Related]
14. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology.
Cheng K; Zhao R; Li Y; Qi Y; Wang Y; Zhang Y; Qin H; Qin Y; Chen L; Li C; Liang J; Li Y; Xu J; Han X; Anderson GJ; Shi J; Ren L; Zhao X; Nie G
Nat Commun; 2021 Apr; 12(1):2041. PubMed ID: 33824314
[TBL] [Abstract][Full Text] [Related]
15. Bacterial Outer Membrane Vesicle-Mediated Cytosolic Delivery of Flagellin Triggers Host NLRC4 Canonical Inflammasome Signaling.
Yang J; Hwang I; Lee E; Shin SJ; Lee EJ; Rhee JH; Yu JW
Front Immunol; 2020; 11():581165. PubMed ID: 33312172
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible bacteria-derived vesicles show inherent antimicrobial activity.
Schulz E; Goes A; Garcia R; Panter F; Koch M; Müller R; Fuhrmann K; Fuhrmann G
J Control Release; 2018 Nov; 290():46-55. PubMed ID: 30292423
[TBL] [Abstract][Full Text] [Related]
17. Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy.
Chen X; Li P; Luo B; Song C; Wu M; Yao Y; Wang D; Li X; Hu B; He S; Zhao Y; Wang C; Yang X; Hu J
ACS Nano; 2024 Jan; 18(2):1357-1370. PubMed ID: 38164903
[TBL] [Abstract][Full Text] [Related]
18. Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.
Shi X; Zhang X; Li J; Guo F; Hu Z; Jing Y; Bai L; Chen S; Wan P; Wang F; Gao J; Tan W
Urol Oncol; 2013 Aug; 31(6):883-93. PubMed ID: 21924648
[TBL] [Abstract][Full Text] [Related]
19. Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model.
Rezaei Adriani R; Mousavi Gargari SL; Bakherad H; Amani J
Sci Rep; 2023 Sep; 13(1):16403. PubMed ID: 37775519
[TBL] [Abstract][Full Text] [Related]
20. Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8
Won S; Lee C; Bae S; Lee J; Choi D; Kim MG; Song S; Lee J; Kim E; Shin H; Basukala A; Lee TR; Lee DS; Gho YS
J Extracell Vesicles; 2023 Aug; 12(8):e12357. PubMed ID: 37563797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
